CDH2 and liver cancer: In in vitro models of liver cancer cell lines, the downregulation of miR-129-3p was associated with a reduced expression of epithelial markers (Cadherin 1 [CDH1] and CTNNB1) and an increase in mesenchymal markers (Cadherin 2 [CDH2] and Vimentin [VIM]) [99]).